Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care ...

Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Products are available through a customizable catalog on Opal, including Bausch + Lomb contact lens brands such as Bausch + Lomb INFUSE®, Bausch + Lomb ULTRA® and Biotrue® ONEday. Over-the ...

over-the-counter products and ophthalmic surgical devices and instruments. Read More on BLCO: Bausch + Lomb Corporation Registered Shs Reg S NewsMORE Related Stocks Indices Commodities ...

The company operates through five main business segments — Bausch + Lomb, Salix Pharmaceuticals, International Rx, Solta ...

Bausch + Lomb Corporation ( (BLCO) ) has realeased its Q3 earnings. Here is a breakdown of the information Bausch + Lomb Corporation presented ...

over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint ...

It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products.

Bausch + Lomb scaled up its revenue guidance for the year after swinging to a profit in the latest quarter on the back of sales growth in each of its business segments.